Research Applications: Tissue Repair & Recovery

If you train hard enough, your tendons will eventually have opinions about it. Tissue-repair research is the oldest, deepest corner of the research-peptide catalog for that reason — there’s more published work, more vendors carrying the compounds, and more variation in quality. The compound has to be what the label says. Below is what we carry, how each compound is studied, and what to verify on a COA before you commit to a vendor.

What this page is for

Tissue-repair research has been the most-cited corner of the research-peptide literature for a long stretch now. The catalog at most research-supply vendors reflects that: synthetic peptide research compounds, copper peptides, growth factors, and the immune-axis compounds that show up alongside in related study designs.

This page is the short version of what’s in CoMo’s tissue-repair catalog, what each compound is studied for in research contexts, and what to check on a COA before you commit to a vendor. It’s not a buying guide — it’s a reference for a researcher deciding which catalog to work from.

For broader context, the Quality Promise covers our operational floor, and How to read a COA covers the document side. Both apply to everything below.

Tissue-repair compounds at a glance

The tissue-repair side of the catalog is more mechanically diverse than the GLP-receptor side. A few notes that save time when reading vendor catalogs:

Synthetic peptide research compounds. BPC-157 and TB-500 are the two most-cited. They aren’t related molecules — BPC-157 is a stable pentadecapeptide derived from gastric protein, while TB-500 (a synthetic version of Thymosin β4) is a larger fragment. Both appear in the same study designs but address different pathways.
Copper peptides. GHK-Cu binds copper and shows up in research on collagen synthesis, fibroblast signaling, and skin/extracellular matrix work.
Growth factors. IGF-1 LR3 is a modified form of IGF-1 with extended half-life. Studied across muscle, tendon, and recovery model designs.
Immune-modulating peptides. Thymosin Alpha-1 and KPV (a fragment of α-MSH) come up in the literature where tissue-repair work intersects with immune signaling and inflammatory pathways.
Blends. Pre-formulated mixes (GLOW = BPC + TB-500 + GHK-Cu, KLOW = GLOW + KPV) exist because the underlying compounds get studied together so often that the combined vials saved researchers and customers the math of stacking individual lots.

Different vendors use slightly different conventions for blend names and growth-factor variants. Always check the COA against the molecule’s calculated mass — at any vendor.

CoMo’s tissue-repair research catalog

Every compound listed here is in current stock. Click through for sizes, current pricing, and the per-batch COA.

BPC-157 — Stable pentadecapeptide derived from a gastric protein sequence. The most-cited research compound on the tissue-repair side. Studied in tendon, ligament, gastrointestinal, and vascular research models.

TB-500 — Synthetic version of Thymosin β4. A larger fragment than BPC-157; studied in muscle and soft-tissue research, often alongside BPC-157 in study designs comparing or combining the two.

BPC-157 / TB-500 Blend — Pre-formulated mix of the two most-cited tissue-repair compounds, in matched ratios. Exists because the combined-study designs are common enough that researchers asked for a single vial.

GHK-Cu (Copper) — Tripeptide bound to copper. Appears in research on collagen synthesis, wound-healing models, fibroblast signaling, and extracellular matrix work. Distinct mechanism from the BPC/TB class.

GLOW — Pre-formulated blend of BPC-157, TB-500, and GHK-Cu in matched ratios (70mg total). The most-purchased item in this category at CoMo; covers the three most-cited tissue-repair compounds in one vial.

KLOW — GLOW plus KPV, the immune-axis tripeptide fragment. Pre-formulated for research designs that span tissue repair and inflammation pathways simultaneously.

KPV — Tripeptide fragment of α-MSH. Studied for anti-inflammatory pathways; appears in tissue-repair literature where inflammation and repair signaling intersect.

IGF-1 LR3 — Long-acting modified form of insulin-like growth factor 1. The R3 substitution extends half-life. Studied across muscle, tendon, and growth-factor signaling research designs. Often included in protocols studying compounded growth-axis effects.

Thymosin Alpha-1 — Naturally-occurring 28-amino-acid peptide derived from prothymosin α. Most-cited in immune-modulation research; appears in tissue-repair work where immune signaling and recovery models overlap.

If you’d rather see the whole tissue-repair slice of the catalog in grid form, the Tissue Repair chip on /shop/ filters down to this set.

The Tissue Repair Bundle

If you’re running a study that pulls from the synthetic-peptide and growth-factor sides at the same time, the Tissue Repair Bundle groups two compounds at a 10% discount versus buying them individually:

GLOW (BPC-157 + TB-500 + GHK-Cu blend)
IGF-1 LR3

The bundle composition pairs the three-compound blend with a growth-factor research compound — a combination that comes up often enough in tissue-repair study designs to be worth a single-click path. As with any bundle, it’s a convenience for the way the catalog actually moves, not a recommendation about how anyone should design a study.

Why purity is the variable that matters in tissue-repair research

The BPC-family and TB-family compounds are well-characterized at the chemistry side. Most of the published work assumes the compound under study is the compound on the label — and that assumption fails quietly when synthesis is sloppy or QC is light. The blends compound the problem: a 70mg vial that claims three compounds in matched ratios needs all three to be on-spec, individually, before the ratio means anything.

Two specific things to look at on a COA in this class:

Identity confirmation via mass spectrometry. Each of the tissue-repair compounds has a well-characterized theoretical mass. The observed mass on the COA should match within a small tolerance. For blends, each component should be characterized; a single summary number isn’t enough.
HPLC purity threshold and methodology. ≥98% is the modern research-supply baseline. The chromatogram itself — not just the summary number — is the real data.

For the full read on what a COA should show, see How to read a COA. That page is vendor-agnostic; the standards there apply to any peptide supplier, including us.

How CoMo handles this

The same operational floor that applies to everything in the catalog applies to the tissue-repair line:

Every batch is HPLC-tested at ≥98% purity by a third-party lab.
For blends, each component is characterized — not just a single summary number.
Every batch gets a per-lot COA, retrievable by SKU at /certificates-of-analysis/.
The lot number on the COA matches what ships.
If a vial fails purity testing, we don’t sell the batch.

Beyond that, the rest of the CoMo Quality Promise — same-day shipping, 12-hour email response, vial-integrity replacement — applies the same way it does for the rest of the catalog.

We train. We carry these compounds because the lifters and researchers in our community asked us to. Family-owned, based in Columbia, MO. We’re not the only vendor doing this honestly. We just want you to be able to verify it for yourself rather than take our word for it.

Note: All CoMo Peptides products are intended for research purposes only and are not approved for human or animal consumption. All products are shipped in lyophilized form and must be reconstituted to a liquid for research and testing. We are unable to provide any dosing instructions. All products should be considered pharmaceutical grade. Per-mg or size-normalized information shown on any product page is a size-normalized value comparison only — not a dosing recommendation.